DAVE INC (DAVE)

US23834J2015 - Common Stock

48  +4.28 (+9.79%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DAVE. DAVE was compared to 276 industry peers in the Software industry. DAVE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DAVE is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

DAVE had negative earnings in the past year.
In the past year DAVE had a positive cash flow from operations.
DAVE had negative earnings in 4 of the past 5 years.
In the past 5 years DAVE reported 4 times negative operating cash flow.

1.2 Ratios

DAVE has a worse Return On Assets (-16.50%) than 63.14% of its industry peers.
The Return On Equity of DAVE (-55.73%) is worse than 66.79% of its industry peers.
Industry RankSector Rank
ROA -16.5%
ROE -55.73%
ROIC N/A
ROA(3y)-23.39%
ROA(5y)-15.63%
ROE(3y)-76.11%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DAVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

DAVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DAVE has been increased compared to 1 year ago.
The debt/assets ratio for DAVE is higher compared to a year ago.

2.2 Solvency

DAVE has an Altman-Z score of 1.98. This is not the best score and indicates that DAVE is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.98, DAVE perfoms like the industry average, outperforming 50.37% of the companies in the same industry.
The Debt to FCF ratio of DAVE is 7.17, which is on the high side as it means it would take DAVE, 7.17 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 7.17, DAVE perfoms like the industry average, outperforming 57.30% of the companies in the same industry.
A Debt/Equity ratio of 2.07 is on the high side and indicates that DAVE has dependencies on debt financing.
DAVE has a Debt to Equity ratio of 2.07. This is amonst the worse of the industry: DAVE underperforms 80.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF 7.17
Altman-Z 1.98
ROIC/WACCN/A
WACC9.43%

2.3 Liquidity

A Current Ratio of 10.81 indicates that DAVE has no problem at all paying its short term obligations.
DAVE's Current ratio of 10.81 is amongst the best of the industry. DAVE outperforms 97.45% of its industry peers.
DAVE has a Quick Ratio of 10.81. This indicates that DAVE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 10.81, DAVE belongs to the best of the industry, outperforming 97.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.81
Quick Ratio 10.81

4

3. Growth

3.1 Past

DAVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.85%, which is quite impressive.
The Revenue has grown by 26.48% in the past year. This is a very strong growth!
Measured over the past years, DAVE shows a very strong growth in Revenue. The Revenue has been growing by 28.61% on average per year.
EPS 1Y (TTM)64.85%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q102.33%
Revenue 1Y (TTM)26.48%
Revenue growth 3Y28.61%
Revenue growth 5YN/A
Revenue growth Q2Q22.52%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-85.38%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DAVE. In the last year negative earnings were reported.
Also next year DAVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, DAVE is valued cheaply inside the industry as 85.04% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 23.34
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DAVE!.
Industry RankSector Rank
Dividend Yield N/A

DAVE INC

NASDAQ:DAVE (4/29/2024, 1:09:52 PM)

48

+4.28 (+9.79%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap587.52M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.5%
ROE -55.73%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 2.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 10.81
Quick Ratio 10.81
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)64.85%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-85.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.48%
Revenue growth 3Y28.61%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y